DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Scott Weiner will join a panel discussion around perspectives on biotechnology transfer and investments at GTC’s Biotechnology Transfer & Commercialization Conference, October 24-26, 2012 in Philadelphia, PA.
News | 07. 31. 2012
Scott Weiner will join a panel discussion around perspectives on biotechnology transfer and investments at GTC’s Biotechnology Transfer & Commercialization Conference, October 24-26, 2012 in Philadelphia, PA.
